195 research outputs found
A Large Imaging Database and Novel Deep Neural Architecture for Covid-19 Diagnosis
Deep learning methodologies constitute nowadays the main approach for medical image analysis and disease prediction. Large annotated databases are necessary for developing these methodologies; such databases are difficult to obtain and to make publicly available for use by researchers and medical experts. In this paper, we focus on diagnosis of Covid-19 based on chest 3-D CT scans and develop a dual knowledge framework, including a large imaging database and a novel deep neural architecture. We introduce COV19-CT-DB, a very large database annotated for COVID-19 that consists of 7,750 3-D CT scans, 1,650 of which refer to COVID-19 cases and 6,100 to non-COVID-19 cases. We use this database to train and develop the RACNet architecture. This architecture performs 3-D analysis based on a CNN-RNN network and handles input CT scans of different lengths, through the introduction of dynamic routing, feature alignment and a mask layer. We conduct a large experimental study that illustrates that the RACNet network has the best performance compared to other deep neural networks i) when trained and tested on COV19-CT-DB; ii) when tested, or when applied, through transfer learning, to other public databases.
Index Terms— medical imaging, COVID-19 diagnosis, COV19-CT-DB database, 3D chest CT scan analysis, RACNet deep neural network, dynamic routing, mask layer, feature alignment
A Deep Neural Architecture for Harmonizing 3-D Input Data Analysis and Decision Making in Medical Imaging
Harmonizing the analysis of data, especially of 3-D image volumes, consisting of different number of slices and annotated per volume, is a significant problem in training and using deep neural networks in various applications, including medical imaging. Moreover, unifying the decision making of the networks over different input datasets is crucial for the generation of rich data-driven knowledge and for trusted usage in the applications. This paper presents a new deep neural architecture, named RACNet, which includes routing and feature alignment steps and effectively handles different input lengths and single annotations of the 3-D image inputs, whilst providing highly accurate decisions. In addition, through latent variable extraction from the trained RACNet, a set of anchors are generated providing further insight on the network's decision making. These can be used to enrich and unify data-driven knowledge extracted from different datasets. An extensive experimental study illustrates the above developments, focusing on COVID-19 diagnosis through analysis of 3-D chest CT scans from databases generated in different countries and medical centers
AI-MIA: COVID-19 Detection and Severity Analysis through Medical Imaging
This paper presents the baseline approach for the organized 2nd Covid-19 Competition, occurring in the framework of the AIMIA Workshop in the European Conference on Computer Vision (ECCV 2022). It presents the COV19-CT-DB database which is annotated for COVID-19 detection,
consisting of about 7,700 3-D CT scans. Part of the database consisting of Covid-19 cases is further annotated in terms of four Covid-19 severity conditions. We have split the database and the latter part of it in training, validation and test datasets. The former two datasets are used for training and validation of machine learning models, while the latter is used for evaluation of the developed models. The baseline approach consists of a deep learning approach, based on a CNN-RNN network and report its performance on the COVID19-CT-DB database. The paper presents the results of both Challenges organised in the framework of the Competition, also compared to the performance of the baseline scheme
FaceRNET: a Facial Expression Intensity Estimation Network
This paper presents our approach for Facial Expression Intensity Estimation
from videos. It includes two components: i) a representation extractor network
that extracts various emotion descriptors (valence-arousal, action units and
basic expressions) from each videoframe; ii) a RNN that captures temporal
information in the data, followed by a mask layer which enables handling
varying input video lengths through dynamic routing. This approach has been
tested on the Hume-Reaction dataset yielding excellent results
Fast quantum state reconstruction via accelerated non-convex programming
We propose a new quantum state reconstruction method that combines ideas from
compressed sensing, non-convex optimization, and acceleration methods. The
algorithm, called Momentum-Inspired Factored Gradient Descent (\texttt{MiFGD}),
extends the applicability of quantum tomography for larger systems. Despite
being a non-convex method, \texttt{MiFGD} converges \emph{provably} to the true
density matrix at a linear rate, in the absence of experimental and statistical
noise, and under common assumptions. With this manuscript, we present the
method, prove its convergence property and provide Frobenius norm bound
guarantees with respect to the true density matrix. From a practical point of
view, we benchmark the algorithm performance with respect to other existing
methods, in both synthetic and real experiments performed on an IBM's quantum
processing unit. We find that the proposed algorithm performs orders of
magnitude faster than state of the art approaches, with the same or better
accuracy. In both synthetic and real experiments, we observed accurate and
robust reconstruction, despite experimental and statistical noise in the
tomographic data. Finally, we provide a ready-to-use code for state tomography
of multi-qubit systems.Comment: 46 page
Adiponectin levels and expression of adiponectin receptors in isolated monocytes from overweight patients with coronary artery disease
Genetic variation in the adiponectin receptor 2 (ADIPOR2) gene is associated with coronary artery disease and increased ADIPOR2 expression in peripheral monocytes
Practical Recommendations for Optimal Thromboprophylaxis in Patients with COVID-19:A Consensus Statement Based on Available Clinical Trials
Coronavirus disease 2019 (COVID-19) has been shown to be strongly associated with increased risk for venous thromboembolism events (VTE) mainly in the inpatient but also in the outpatient setting. Pharmacologic thromboprophylaxis has been shown to offer significant benefits in terms of reducing not only VTE events but also mortality, especially in acutely ill patients with COVID-19. Although the main source of evidence is derived from observational studies with several limitations, thromboprophylaxis is currently recommended for all hospitalized patients with acceptable bleeding risk by all national and international guidelines. Recently, high quality data from randomized controlled trials (RCTs) further support the role of thromboprophylaxis and provide insights into the optimal thromboprophylaxis strategy. The aim of this statement is to systematically review all the available evidence derived from RCTs regarding thromboprophylaxis strategies in patients with COVID-19 in different settings (either inpatient or outpatient) and provide evidence-based guidance to practical questions in everyday clinical practice. Clinical questions accompanied by practical recommendations are provided based on data derived from 20 RCTs that were identified and included in the present study. Overall, the main conclusions are: (i) thromboprophylaxis should be administered in all hospitalized patients with COVID-19, (ii) an optimal dose of inpatient thromboprophylaxis is dependent upon the severity of COVID-19, (iii) thromboprophylaxis should be administered on an individualized basis in post-discharge patients with COVID-19 with high thrombotic risk, and (iv) thromboprophylaxis should not be routinely administered in outpatients. Changes regarding the dominant SARS-CoV-2 variants, the wide immunization status (increasing rates of vaccination and reinfections), and the availability of antiviral therapies and monoclonal antibodies might affect the characteristics of patients with COVID-19; thus, future studies will inform us about the thrombotic risk and the optimal therapeutic strategies for these patients
- …